Spatial OMICS Market Research Report by Technology, Sample Type, Product, Workflow, End-use, Country - North America Forecast to 2027 - Cumulative Impact of COVID-19

The North America Spatial OMICS Market size was estimated at USD 91.72 million in 2021 and expected to reach USD 102.74 million in 2022, and is projected to grow at a CAGR 12.61% to reach USD 187.06 million by 2027.

Market Statistics:
The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:
This research report categorizes the Spatial OMICS to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Technology, the market was studied across Genomics, Proteomics, and Transcriptomics.

Based on Sample Type, the market was studied across FFPE and Fresh Frozen.

Based on Product, the market was studied across Consumables, Instruments, and Software. The Instruments is further studied across Flow Cytometry, IHC, Mass Spectrometry, Microscopy, and Sequencing Platforms. The Software is further studied across Bioinformatics Tools, Imaging Tools, and Storage & Management Databases.

Based on Workflow, the market was studied across Data Analysis, Instrumental Analysis, and Sample Preparation.

Based on End-use, the market was studied across Academic & Translational Research Institutes and Pharmaceutical and Biotechnology Companies.

Based on Country, the market was studied across Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Spatial OMICS market considering the current update on the conflict and its global response.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Spatial OMICS Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the North America Spatial OMICS Market, including 10x Genomics, Inc., Akoya Biosciences, Inc., Bio-Techne Corporation, Biognosys AG, BioSpyder Technologies Inc., Bruker Corporation, Danaher Corporation, Dovetail Genomics, LLC, Fluidigm Corporation, IonPath, Inc., NanoString Technologies, Inc., PerkinElmer, Inc., Rebus Biosystems, Inc., S2 Genomics, Inc., Seven Bridges Genomics Inc, Ultivue, Inc., and Vizgen, Inc..

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the North America Spatial OMICS Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the North America Spatial OMICS Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the North America Spatial OMICS Market?
4. What is the competitive strategic window for opportunities in the North America Spatial OMICS Market?
5. What are the technology trends and regulatory frameworks in the North America Spatial OMICS Market?
6. What is the market share of the leading vendors in the North America Spatial OMICS Market?
7. What modes and strategic moves are considered suitable for entering the North America Spatial OMICS Market?

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19

6. Spatial OMICS Market, by Technology
6.1. Introduction
6.2. Genomics
6.3. Proteomics
6.4. Transcriptomics

7. Spatial OMICS Market, by Sample Type
7.1. Introduction
7.2. FFPE
7.3. Fresh Frozen

8. Spatial OMICS Market, by Product
8.1. Introduction
8.2. Consumables
8.3. Instruments
8.4.1. Flow Cytometry
8.4.2. IHC
8.4.3. Mass Spectrometry
8.4.4. Microscopy
8.4.5. Sequencing Platforms
8.4. Software
8.5.1. Bioinformatics Tools
8.5.2. Imaging Tools
8.5.3. Storage & Management Databases

9. Spatial OMICS Market, by Workflow
9.1. Introduction
9.2. Data Analysis
9.3. Instrumental Analysis
9.4. Sample Preparation

10. Spatial OMICS Market, by End-use
10.1. Introduction
10.2. Academic & Translational Research Institutes
10.3. Pharmaceutical and Biotechnology Companies

11. Canada Spatial OMICS Market
11.1. Introduction

12. Mexico Spatial OMICS Market
12.1. Introduction

13. United States Spatial OMICS Market
13.1. Introduction

14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis, By Key Player
14.3. Market Share Analysis, By Key Player
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion

15. Company Usability Profiles
15.1. 10x Genomics, Inc.
15.1.1. Business Overview
15.1.2. Key Executives
15.1.3. Product & Services
15.2. Akoya Biosciences, Inc.
15.2.1. Business Overview
15.2.2. Key Executives
15.2.3. Product & Services
15.3. Bio-Techne Corporation
15.3.1. Business Overview
15.3.2. Key Executives
15.3.3. Product & Services
15.4. Biognosys AG
15.4.1. Business Overview
15.4.2. Key Executives
15.4.3. Product & Services
15.5. BioSpyder Technologies Inc.
15.5.1. Business Overview
15.5.2. Key Executives
15.5.3. Product & Services
15.6. Bruker Corporation
15.6.1. Business Overview
15.6.2. Key Executives
15.6.3. Product & Services
15.7. Danaher Corporation
15.7.1. Business Overview
15.7.2. Key Executives
15.7.3. Product & Services
15.8. Dovetail Genomics, LLC
15.8.1. Business Overview
15.8.2. Key Executives
15.8.3. Product & Services
15.9. Fluidigm Corporation
15.9.1. Business Overview
15.9.2. Key Executives
15.9.3. Product & Services
15.10. IonPath, Inc.
15.10.1. Business Overview
15.10.2. Key Executives
15.10.3. Product & Services
15.11. NanoString Technologies, Inc.
15.11.1. Business Overview
15.11.2. Key Executives
15.11.3. Product & Services
15.12. PerkinElmer, Inc.
15.12.1. Business Overview
15.12.2. Key Executives
15.12.3. Product & Services
15.13. Rebus Biosystems, Inc.
15.13.1. Business Overview
15.13.2. Key Executives
15.13.3. Product & Services
15.14. S2 Genomics, Inc.
15.14.1. Business Overview
15.14.2. Key Executives
15.14.3. Product & Services
15.15. Seven Bridges Genomics Inc
15.15.1. Business Overview
15.15.2. Key Executives
15.15.3. Product & Services
15.16. Ultivue, Inc.
15.16.1. Business Overview
15.16.2. Key Executives
15.16.3. Product & Services
15.17. Vizgen, Inc.
15.17.1. Business Overview
15.17.2. Key Executives
15.17.3. Product & Services

16. Appendix
16.1. Discussion Guide
16.2. License & Pricing